Cardinal Health 2011 Annual Report Download - page 35

Download and view the complete annual report

Please find page 35 of the 2011 Cardinal Health annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 122

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122

with various export control and trade embargo laws and regulations, which may require licenses or other
a
ut
h
or
i
zat
i
ons
f
or transact
i
ons w
i
t
hi
n some countr
i
es or w
i
t
h
some counterpart
i
es. A
l
so, we must a
bid
e
b
yUn
i
te
d
States and forei
g
n customs laws and re
g
ulations
.
S
imilarly, we are subject to laws and regulations concerning the conduct of our foreign operations, including
t
h
eUn
i
te
d
States Fore
i
gn Corrupt Pract
i
ces Act,
f
ore
i
gn ant
i
-
b
r
ib
ery
l
aws an
dl
aws perta
i
n
i
ng to t
h
e accuracy o
f
internal books and records. These laws
g
enerall
y
prohibit companies and their intermediaries from offerin
g
,
promising or making payments to non-United States government officials for the purpose of obtaining o
r
reta
i
n
i
ng
b
us
i
ness
.
O
ther In
f
ormat
i
o
n
O
ur distribution businesses are generally not required by our customers to maintain particular inventor
y
l
eve
l
sot
h
er t
h
an as nee
d
e
d
to meet serv
i
ce
l
eve
l
requ
i
rements. Certa
i
n supp
l
y contracts w
i
t
h
Un
i
te
d
States
g
overnment entities require us to maintain sufficient inventor
y
to meet emer
g
enc
y
demands, but we do not
believe those requirements materially affect inventory levels.
O
ur customer return po
li
c
i
es genera
ll
y requ
i
re t
h
at t
h
e pro
d
uct
b
ep
h
ys
i
ca
ll
y returne
d
,su
bj
ect to restoc
ki
ng
f
ees. We onl
y
allow customers to return products that can be added back to inventor
y
and resold at full value, o
r
that can be returned to vendors for credit. We offer market payment terms to our customers.
R
evenue and Lon
g
-L
i
ved Assets by
G
eo
g
raph
i
c Are
a
S
ee Note 16 of the “Notes to Consolidated Financial Statements” for revenue and lon
g
-lived assets b
y
g
eographic area
.
A
va
i
lable In
f
ormat
i
on and Exchan
g
e
C
ert
ifi
cat
i
ons
O
ur Annual Report on Form 10-K, Quarterl
y
Reports on Form 10-Q, Current Reports on Form 8-K, and
a
mendments to those reports are available free of charge on our website (www.cardinalhealth.com), under the
“Investors—F
i
nanc
i
a
l
s/SEC
fili
ngs” capt
i
on, as soon as reasona
bl
y pract
i
ca
bl
ea
f
ter we e
l
ectron
i
ca
ll
y
fil
et
h
em
with, or furnish them to, the Securities and Exchan
g
e Commission (the “SEC”).
You may read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 100
F
Street, NE, Washington, DC 20549. You may obtain information on the operation of the Public Reference Room
b
y
callin
g
the SEC at 1-800-SEC-0330. The SEC also maintains a website (www.sec.
g
ov) where
y
ou can searc
h
f
or annual, quarterly and current reports, proxy and information statements, and other information regarding us
a
n
d
ot
h
er pu
bli
c compan
i
es
.
I
t
e
m 1A: Risk F
a
ctor
s
T
he risks described below could materially and adversely affect our results of operations, financial
con
di
t
i
on,
li
qu
idi
ty an
d
cas
hfl
ows. T
h
ese are not t
h
eon
l
yr
i
s
k
swe
f
ace. Our
b
us
i
nesses a
l
so cou
ld b
ea
ff
ecte
db
y
risks that we are not presentl
y
aware of or that we currentl
y
consider immaterial to our operations.
W
e could suffer the adverse effects of competitive pressures.
A
s
d
escr
ib
e
di
n greater
d
eta
il i
nt
h
e
di
scuss
i
on o
f
our
b
us
i
ness
i
n Item 1 a
b
ove, we operate
i
n mar
k
ets t
h
a
t
a
re hi
g
hl
y
competitive. Because of competition, our businesses face continued pricin
g
pressure from ou
r
customers and suppliers. If we are unable to offset margin reductions caused by these pricing pressures throug
h
steps suc
h
as en
h
ance
d
cost contro
l
measures, our resu
l
ts o
f
operat
i
ons an
dfi
nanc
i
a
l
con
di
t
i
on cou
ld b
e
a
dversel
y
affected
.
I
n addition, in recent years, the healthcare industry has continued to consolidate. Further consolidatio
n
a
mong our customers an
d
supp
li
ers (
i
nc
l
u
di
ng
b
ran
d
e
d
p
h
armaceut
i
ca
l
manu
f
acturers) cou
ld
g
i
ve t
h
e resu
l
t
i
ng
enterprises
g
reater bar
g
ainin
g
power, which ma
y
adversel
y
impact our results of operations.
9